| Wellnex Life Limited (WNX) ORDINARY FULLY PAID |
Consumer Staple |
$4 |
Extension of Haleon Licensing and Supply Agreement
|
2 Apr 2026 9:39AM |
$0.073 |
$0.055 |
fallen by
24.66%
|
|
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$155 |
Application for quotation of securities - AR1
|
2 Apr 2026 9:38AM |
$0.088 |
$0.062 |
fallen by
29.55%
|
|
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$25,031 |
Notification of cessation of securities - BXB
|
2 Apr 2026 9:38AM |
$22.910 |
$18.740 |
fallen by
18.20%
|
|
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$26 |
TGA Accepts Initial Registration Dossier for Evaluation
|
2 Apr 2026 9:38AM |
$0.017 |
$0.013 |
fallen by
23.53%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Algorae Pharmaceuticals Ltd (ASX: 1AI) has announced that the TGA has accepted its initial registration dossier for evaluation.
- The acceptance by TGA indicates the dossier met preliminary assessment requirements and will proceed to formal evaluation.
- This is a significant milestone for Algorae in its effort to commercialize products in the Australian market.
- Acceptance of the application does not guarantee the outcome of the evaluation.
- Algorae will provide regular updates on the progress of TGA applications.
- The dossier includes the first of multiple planned TGA registration submissions.
- Algorae's commercial division, AlgoraeRx, has agreements with Sakar Healthcare Limited and Cadila Pharmaceuticals Limited.
- The product in the submission is intended for the Australian and New Zealand markets.
- Algorae Pharmaceuticals employs its proprietary AI platform, AlgoraeOS, for drug-combination discovery and commercialisation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Daintree Hybrid Opportunities Fund (Managed Fund) (DHOF) |
Financials |
$37 |
DHOF Quarterly Final Distribution
|
2 Apr 2026 9:38AM |
$9.520 |
$9.580 |
risen by
0.63%
|
|
| Nido Education Limited (NDO) ORDINARY FULLY PAID |
Consumer Discretionary |
$91 |
2025 Transparency Report
|
2 Apr 2026 9:37AM |
$0.400 |
$0.400 |
fallen by
0%
|
|
| HeraMED Limited (HMD) ORDINARY FULLY PAID |
Health Care |
$42 |
Application for quotation of securities - HMD
|
2 Apr 2026 9:37AM |
$0.050 |
$0.036 |
fallen by
28%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$16 |
Proposed issue of securities - W2V
|
2 Apr 2026 9:37AM |
$0.074 |
$0.060 |
fallen by
18.92%
|
|
| Way 2 Vat Ltd (W2V) ORDINARY FULLY PAID |
Information Technology |
$16 |
Way2VAT completes A$2,600,000 Placement
|
2 Apr 2026 9:37AM |
$0.074 |
$0.060 |
fallen by
18.92%
|
|
W2V - Price-sensitive ASX Announcement
Full Release
Key Points
- Way2VAT raises A$2,600,000 via placement at A$0.07 per share.
- Funds to repay debt and support working capital.
- Placement supported by new and existing investors.
- Shares issued under existing ASX placement capacity.
- Placement shares at a 5.4% discount to last closing price.
- Six-month voluntary escrow on placement shares.
- Settlement expected on or about 7 April 2026.
- Issuance of options subject to shareholder approval.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bapcor Limited (BAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$286 |
Notification regarding unquoted securities - BAP
|
2 Apr 2026 9:36AM |
$0.630 |
$0.425 |
fallen by
32.54%
|
|
| Bapcor Limited (BAP) ORDINARY FULLY PAID |
Consumer Discretionary |
$286 |
Notification of cessation of securities - BAP
|
2 Apr 2026 9:36AM |
$0.630 |
$0.425 |
fallen by
32.54%
|
|
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$227 |
Update - Notification of buy-back - PCX
|
2 Apr 2026 9:36AM |
$1.970 |
$2.000 |
risen by
1.52%
|
|
| QPM Energy Limited (QPM) ORDINARY FULLY PAID |
Materials |
$36 |
Trading Halt
|
2 Apr 2026 9:36AM |
$0.031 |
$0.009 |
fallen by
70.97%
|
|
QPM - Price-sensitive ASX Announcement
Full Release
Key Points
- QPM Energy Limited requests trading halt.
- Trading halt related to Isaac Power Station financing announcement.
- Halt to last until announcement or Wednesday, 8 April 2026.
- Board authorized the trading halt.
- No additional undisclosed information or reasons.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$89 |
LRT NAV Estimate - 31 March 2026
|
2 Apr 2026 9:36AM |
$2.230 |
$2.140 |
fallen by
4.04%
|
|
| Garda Diversified Property Fund (GDF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$226 |
Notification of buy-back - GDF
|
2 Apr 2026 9:36AM |
$1.080 |
$1.040 |
fallen by
3.70%
|
|
| Hydrocarbon Dynamics Limited (HCD) ORDINARY FULLY PAID |
Energy |
- |
Prospectus
|
2 Apr 2026 9:36AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| MAAS Group Holdings Limited (MGH) ORDINARY FULLY PAID |
Industrials |
$2,060 |
Update - Notification of buy-back - MGH
|
2 Apr 2026 9:34AM |
$4.350 |
$5.700 |
risen by
31.03%
|
|
| Austral Resources Australia Ltd (AR1) ORDINARY FULLY PAID |
Materials |
$155 |
Application for quotation of securities - AR1
|
2 Apr 2026 9:34AM |
$0.088 |
$0.062 |
fallen by
29.55%
|
|
| Frontier Digital Ventures Limited (FDV) ORDINARY FULLY PAID |
Communication Services |
$148 |
Appendix 4G and Corporate Governance Statement
|
2 Apr 2026 9:34AM |
$0.330 |
$0.340 |
risen by
3.03%
|
|
| Pathkey.AI Ltd (PKY) ORDINARY FULLY PAID |
Information Technology |
$48 |
PKY Secures Key Commercial Contract with Imunexus
|
2 Apr 2026 9:34AM |
$0.023 |
$0.040 |
risen by
73.91%
|
|
PKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Pathkey.AI Ltd announced a key commercial contract with Imunexus Therapeutics Ltd valued at up to A$100,000 plus GST.
- The contract demonstrates the real-world commercial adoption of Pathkey's TrialKey platform.
- It positions Pathkey for future engagements and is expected to contribute to FY26 and FY27 revenue.
- The agreement is effective from 1 April 2026, with A$25,000 plus GST payable upon execution.
- Further payments are conditional on Imunexus completing future capital raisings and achieving specific milestones.
- The contract has an initial term of one year with potential for repeatable engagements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Emyria Limited (EMD) ORDINARY FULLY PAID |
Health Care |
$32 |
EMD Commences NSW Workforce Recruitment To Support Expansion
|
2 Apr 2026 9:33AM |
$0.050 |
$0.040 |
fallen by
20%
|
|
EMD - Price-sensitive ASX Announcement
Full Release
Key Points
- Emyria Limited has launched a targeted recruitment campaign in New South Wales to support national expansion.
- The campaign focuses on hiring therapists and psychiatrists in Sydney to establish Emyria's fourth state-based clinical operation.
- New South Wales is identified as a strategic priority due to its large patient population and significant mental health demand.
- Psychological injury claims in NSW increased by 64% between 2019-20 and 2023-24.
- Emyria’s national workforce currently includes over 90 trained therapists across Western Australia, Queensland, and Victoria.
- The recruitment campaign aims to accelerate Emyria’s clinical presence in NSW and enhance its evidence-based mental health services.
- Emyria is aligning its expansion with global trends in psychedelic and next-generation mental health therapies.
- The company's efforts are supported by significant global interest and capital inflows in the sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| KMD Brands Limited (KMD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$102 |
Reinstatement to Quotation
|
2 Apr 2026 9:33AM |
$0.155 |
$1.415 |
risen by
812.90%
|
|
KMD - Price-sensitive ASX Announcement
Full Release
Key Points
- KMD Brands Limited's securities reinstated to quotation on ASX.
- Reinstatement followed the completion of a placement and institutional entitlement offer.
- Trading suspension lifted immediately after the announcement.
- ASX Compliance issued the market announcement.
- Indicates financial and strategic progress by KMD.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Articore Group Limited (ATG) ORDINARY FULLY PAID |
Consumer Discretionary |
$82 |
Update - Notification of buy-back - ATG
|
2 Apr 2026 9:33AM |
$0.325 |
$0.280 |
fallen by
13.85%
|
|
| KMD Brands Limited (KMD) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Consumer Discretionary |
$102 |
KMD completes Placement and Institutional Entitlement Offer
|
2 Apr 2026 9:32AM |
$0.155 |
$1.415 |
risen by
812.90%
|
|
KMD - Price-sensitive ASX Announcement
Full Release
Key Points
- KMD Brands Limited successfully completed a $6.8 million placement and institutional component of a $58.5 million entitlement offer.
- The Placement and Institutional Entitlement Offer raised $44.2 million through new shares.
- Retail Entitlement Offer opens on April 7, 2026, expected to raise $21.1 million.
- Shares to resume trading on NZX and ASX on April 13, 2026.
- Retail shareholders can participate at NZ$0.06 per share or A$0.05 using a specified exchange rate.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latitude 66 Limited (LAT) ORDINARY FULLY PAID |
Materials |
$18 |
Trading Halt
|
2 Apr 2026 9:32AM |
$0.128 |
$0.100 |
fallen by
21.57%
|
|
LAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Latitude 66 Ltd (ASX: LAT) requested a trading halt.
- The halt is pending an announcement regarding the KSB Project in Kuusamo, Finland.
- The trading halt is set to end by 8 April 2026 or upon the announcement release.
- LAT provided required information as per ASX Listing Rule 17.1.
- LAT is not aware of any reason the halt should not be granted.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
